A reliable, cryoprotective, xeno-free medium suitable for different cell types is highly desirable in regenerative medicine. There is danger of infection or allergic reaction with the use of fetal bovine serum (FBS), making it problematic for medical applications. The aim of the present study was to develop an FBS-free cryoprotective medium for human mesenchymal stromal cells (hMSCs; primary cells) and immortalized human osteoblasts (SAOS-2 cell line). Furthermore, we endeavored to eliminate or reduce the presence of dimethyl sulfoxide (DMSO) in the medium. Sericin, a sticky protein derived from the silkworm cocoon, was investigated as a substitute for FBS and DMSO in the freezing medium. Cell viability (24 hours after thawing, both hMSC and SAOS-2) and colony-forming ability (2 weeks after thawing, only for hMSCs) were both determined. The FBS-free medium with 1% sericin in 10% DMSO was found to be a suitable freezing medium for primary hMSCs, in contrast to immortalized human osteoblasts. Surprisingly, the storage of hMSCs in a cultivation medium with only 10% DMSO also provided satisfactory results. Any drop in DMSO concentration led to significantly worse survival of cells, with little improvement in hMSC survival in the presence of sericin. Thus, sericin may substitute for FBS in the freezing medium for primary hMSCs, but cannot substitute for DMSO.

Institute of Inherited Metabolic Disorders Faculty of Science Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Pittenger MF, Mackay AM, Beck SC, et al. . Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–147 PubMed

Pytlik R, Stehlik D, Soukup T, et al. . The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Biomaterials 2009;30:3415–3427 PubMed

Jiang YH, Jahagirdar BN, Reinhardt RL, et al. . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41–49 PubMed

Zuk PA, Zhu M, Ashjian P, et al. . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279–4295 PubMed PMC

Gronthos S, Brahim J, Li W, et al. . Stem cell properties of human dental pulp stem cells. J Dental Res 2002;81:531–535 PubMed

Lee OK, Kuo TK, Chen WM, et al. . Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669–1675 PubMed

Abumaree MH, Al Jumah MA, Kalionis B, et al. . Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev Rep 2013;9:16–31 PubMed

Montanucci P, Basta G, Pescara T, et al. . New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Pt A 2011;17:2651–2661 PubMed

Si YL, Zhao YL, Hao HJ, et al. . MSCs: Biological characteristics, clinical applications and their outstanding concerns. Age Res Rev 2011;10:93–103 PubMed

Kon E, Filardo G, Roffi A, et al. . Bone regeneration with mesenchymal stem cells. Clin Cases Mineral Bone Metab 2012;9:24–27 PubMed PMC

Elnakish MT, Hassan F, Dakhlallah D, et al. . Mesenchymal stem cells for cardiac regeneration: Translation to bedside reality. Stem Cells Intl 2012;2012:646038 PubMed PMC

Figueroa FE, Carrion F, Villanueva S, et al. . Mesenchymal stem cell treatment for autoimmune diseases: A critical review. Biol Res 2012;45:269–277 PubMed

Ball LM, Bernardo ME, Roelofs H, et al. . Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease. Br J Haematol 2013;163:501–509 PubMed

Rodan SB, Imai Y, Thiede MA, et al. . Characterization of a human osteosarcoma cell-line (Saos-2) with osteoblastic properties. Cancer Res 1987;47:4961–4966 PubMed

Baust JG, Gao DY, Baust JM. Cryopreservation: An emerging paradigm change. Organogenesis. 2009;5:90–96 PubMed PMC

Qi WD, Ding DL, Salvi RJ. Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures. Hearing Res 2008;236:52–60 PubMed PMC

Wang X, Hua TC, Sun DW, et al. . Cryopreservation of tissue-engineered dermal replacement in Me2SO: Toxicity study and effects of concentration and cooling rates on cell viability. Cryobiology 2007;55:60–65 PubMed

Sasaki M, Kato Y, Yamada H, et al. . Development of a novel serum-free freezing medium for mammalian cells using the silk protein sericin. Biotechnol Appl Bioc 2005;42:183–188 PubMed

Sundin M, Ringden O, Sundberg B, et al. . No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007;92:1208–1215 PubMed

Brockbank KG, Heacox AE, Schenke-Layland K. Guidance for removal of fetal bovine serum from cryopreserved heart valve processing. Cells Tissues Organs 2011;193:264–273 PubMed PMC

Miyamoto Y, Oishi K, Yukawa H, et al. . Cryopreservation of human adipose tissue-derived stem/progenitor cells using the silk protein sericin. Cell Transplant 2012;21:617–622 PubMed

Toyosawa T, Oumi Y, Ogawa A, et al. . Novel serum-free cryopreservation of mammalian cells using sericin. Anima Cell Tech 2009;15:41–45

Aramwit P, Siritientong T, Srichana T. Potential applications of silk sericin, a natural protein from textile industry by-products. Waste Manage Res 2012;30:217–224 PubMed

Aramwit P, Kanokpanont S, Nakpheng T, et al. . The effect of sericin from various extraction methods on cell viability and collagen production. Int J Mol Sci 2010;11:2200–2211 PubMed PMC

Terada S, Takada N, Itoh K, et al. . Silk protein sericin improves mammalian cell culture. Cell Technol Cell Products 2007:397–401

Zhaorigetu S, Yanaka N, Sasaki M, et al. . Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-alpha. Oncol Rep 2003;10:537–543 PubMed

Sasaki M, Kato N, Watanabe H, et al. . Silk protein, sericin, suppresses colon carcinogenesis induced by 1,2-dimethylhydrazine in mice. Oncol Rep 2000;7:1049–1052 PubMed

Cao Y, Wang B. Biodegradation of silk biomaterials. Int J Mol Sci 2009;10:1514–1524 PubMed PMC

Soukup T, Mokry J, Karbanova J, et al. . Mesenchymal stem cells isolated from the human bone marrow: Cultivation, phenotypic analysis and changes in proliferation kinetics. Acta Med 2006;49:27–33 PubMed

Baust JM. Molecular mechanisms of cellular demise associated with cryopreservation failure. Cell Preserv Technol 2002;1:17–31

Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001;98:7841–7845 PubMed PMC

Baust JM, Van Buskirk R, Baust JG. Modulation of the cryopreservation cap: Elevated survival with reduced dimethyl sulfoxide concentration. Cryobiology 2002;45:97–108 PubMed

Ohnishi K, Murakami M, Morikawa M, et al. . Effect of the silk protein sericin on cryopreserved rat islets. J Hepato-Bil-Pan Sci 2012;19:354–360 PubMed

Enhancement of Biomimetic Enzymatic Mineralization of Gellan Gum Polysaccharide Hydrogels by Plant-Derived Gallotannins